JRCT ID: jRCT2080225366
Registered date:27/08/2020
Basic Information
| Recruitment status | completed |
|---|---|
| Health condition(s) or Problem(s) studied | |
| Date of first enrollment | 01/10/2020 |
| Target sample size | 242 |
| Countries of recruitment | Japan,Asia except Japan,North America,Europe,Africa |
| Study type | Interventional |
| Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
| Primary Outcome | safety efficacy |
|---|---|
| Secondary Outcome | safety efficacy pharmacokinetics |
Key inclusion & exclusion criteria
| Age minimum | >= 18age old |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | |
| Exclude criteria |
Related Information
| Primary Sponsor | |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) | NCT03893565,JapicCTI-205462 |
Contact
| Public contact | |
| Name | |
| Address | 4-10-18 Takanawa, Minato-ku,Tokyo 108-0074 Japan |
| Telephone | - |
| 204869_JAPAN_JAPIC@iqvia.com | |
| Affiliation | IQVIA Services Japan K.K. |
| Scientific contact | |
| Name | |
| Address | 4-10-18 Takanawa, Minato-ku,Tokyo 108-0074 Japan |
| Telephone | - |
| 204869_JAPAN_JAPIC@iqvia.com | |
| Affiliation | IQVIA Services Japan K.K. |